CMOs showed an increasing reluctance to take on debt in 2022
SMPA's diverse portfolio includes six marketed products and a robust pipeline of early- to late-stage assets
Proposed divestiture of BioPharma Solutions (BPS) further streamlines Baxter’s strategic focus and represents an important milestone in its ongoing business transformation
The planned bioprocessing facility would support commercial manufacturing for biotech and pharmaceutical customers across Asia-Pacific.
Clinic will offer Comprehensive Genetic Counselling and Testing Services to empower patients with personalized care
The acquisition is a crucial step in LTS' strategy to broaden its portfolio of drug delivery platforms.
Subscribe To Our Newsletter & Stay Updated